Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum
B. Ohlsson
Department of Clinical Sciences, Gastroenterology Division, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorK. Sjöberg
Department of Clinical Sciences, Gastroenterology Division, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorR. Alm
Experimental Cardiovascular Research Unit, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorG. N. Fredrikson
Experimental Cardiovascular Research Unit, Skånes University Hospital, Lund University, Malmö, Sweden
Faculty of Health and Society, Malmö University, Sweden
Search for more papers by this authorB. Ohlsson
Department of Clinical Sciences, Gastroenterology Division, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorK. Sjöberg
Department of Clinical Sciences, Gastroenterology Division, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorR. Alm
Experimental Cardiovascular Research Unit, Skånes University Hospital, Lund University, Malmö, Sweden
Search for more papers by this authorG. N. Fredrikson
Experimental Cardiovascular Research Unit, Skånes University Hospital, Lund University, Malmö, Sweden
Faculty of Health and Society, Malmö University, Sweden
Search for more papers by this authorAbstract
Background The etiology of irritable bowel syndrome (IBS) and dysmotility is in most cases unknown. Organic, pathognomonic changes have not been described. We have previously demonstrated sporadic expressions of antibodies against gonadotropin-releasing hormone (GnRH) in serum from these patients. The aim of this study was to screen for the presence of GnRH antibodies in healthy subjects and patients with gastrointestinal (GI) diseases.
Methods Consecutive patients suffering from either IBS, idiopathic dysmotility, GI complaints secondary to diabetes mellitus, celiac disease or inflammatory bowel disease (IBD) were included. Healthy blood donors served as controls. Blood samples were taken for analyzing IgM and IgG antibodies against GnRH using an ELISA method. Medical records were scrutinized with respect to duration of symptoms, co-existing diseases, drug treatments, hereditary factors, and laboratory analyses.
Key Results Healthy controls expressed low levels of GnRH IgM antibodies in a prevalence of 23%. The prevalence of GnRH IgM antibodies in IBS and dysmotility patients was 42% (P = 0.008), and the levels were higher (P = 0.000). Patients with diabetes mellitus expressed GnRH IgM antibodies in the same prevalence as controls (25%), but in higher levels (P = 0.02). Patients with celiac disease or IBD had the same or lower levels of antibodies. There were no associations between antibodies, other co-existing diseases or laboratory analyses.
Conclusions & Inferences Higher levels of GnRH IgM antibodies were detected in patients with IBS and dysmotility, but not organic GI diseases, compared with healthy controls. These findings suggest that IBS and dysmotility to some extent may be of an autoimmune origin.
References
- 1 Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480–91.
- 2 Ohlsson B, Melander O, Thorson O, Olsson R, Ekberg O, Sundkvist G. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia 2006; 49: 2010–4.
- 3 Ohlsson B, Scheja A, Janciauskiene S, Mandl T. GnRH-antibodies and gastrointestinal complaints in patients with Sjögren′s syndrome and progressive systemic sclerosis. Scand J Rheumatol 2009; 23: 1–2.
- 4 Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: The impact of gender predominant bowel pattern. Scand J Gastroenterol 2001; 36: 545–52.
- 5 Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001; 121: 799–804.
- 6 Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693–702.
- 7 Mearin F, Perelló A, Balboa A et al. Pathological mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol 2009; 44: 1173–85.
- 8 Ohlsson B, Veréss B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A. Chronic intestinal pseudo-obstruction due to buserelin-induced formation of anti-GnRH antibodies. Gastroenterology 2007; 132: 45–51.
- 9 Ohlsson B, Veress B, Ekblad E, Montgomery A, Janciauskiene S. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. BMC Gastroenterology 2010; 10: 48.
- 10 Collins PJ, Horowitz M, Cook DJ, Harding PE, Shearman DJ. Gastric emptying in normal subjects: a reproducible technique using a single scintillation camera and computer system. Gut 1983; 24: 1117–25.
- 11 Hanson M, Lilja B. Gastric emptying in smokers. Scand J Gastroenterol 1987; 22: 1102–4.
- 12 Castell JA, Dalton CB, Castell DO. On-line computer analysis of human lower esophageal sphincter relaxation. Am J Physiol 1988; 255: G794–9.
- 13 Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroenterol 1988; 23: 72–80.
- 14 Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001; 49: 145–51.
- 15 De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004; 53: 1549–52.
- 16 Wingate D, Hongo M, Kellow J, Lindberg G, Smout A. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002; 17(Suppl): S1–14.
- 17 Sjoberg K, Eriksson S. Regional differences in celiac disease prevalence in Scandinavia? Scand J Gastroenterol 1999; 34: 41–5.
- 18 Klooker TK, Braak B, Koopman KE et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213–21.
- 19 De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep 2008; 10: 385–90.
- 20 Sjoberg K, Eriksson S, Tenngart B, Roth B, Leffler H, Stenberg P. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Autoimmunity 2002; 35: 357–64.
- 21 Arai R. Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease. Postgrad Med 2010; 122: 177–85.
- 22 Öhman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163–73.
- 23 Ho JS, Nagle GT, Mathias JR et al. Presence of gonadotropin-releasing hormone (GnRH) receptor mRNA in rat myenteric plexus cells. Comp Biochem Physiol B Biochem Mol Biol 1996; 113: 817–21.
- 24 Huang W, Yao B, Sun L, Pu R, Wang L, Zhang R. Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 2001; 68: 1727–34.
- 25 Welch MG, Tamir H, Gross KJ, Chen J, Anwar M, Gershon MD. Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium. J Comp Neurol 2009; 512: 256–70.
- 26 Soldani G, Del Tacca MM, Bambini G et al. Effects of gonadotropin-releasing hormone (GnRH) on gastric secretion and gastrin release in the dog. Drug Metab Dispos 1993; 21: 818–22.
- 27 Khanna R, Browne RM, Heiner AD, Clench MH, Mathias JR. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992; 262: G185–90.
- 28 Mathias JR, Baskin GS, Reeves-Darby VG, Clench MH, Smith LL, Calhoon JH. Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate. Dig Dis Sci 1992; 37: 1761–8.
- 29 Mathias JR, Franklin R, Quast DC et al. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril 1998; 70: 81–8.
- 30 McLeod BS, Retzloff MG. Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol 2010; 53: 389–96.
- 31 Mathias JR, Clench MH, Reeves-Darby VG et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Dig Dis Sci 1994; 39: 1155–62.
- 32 Mathias JR, Clench MH, Abell TL et al. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998; 43: 1347–55.
- 33 Palomba S, Orio F, Manguso F et al. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. Fertil Steril 2005; 83: 1012–20.
- 34 Ducker TE, Boss JW, Altug SA et al. Luteinizing hormone and human chorionic gonadotropin fragment the migrating myoelectric complex in rat small intestine. Neurogastroenterol Motil 1996; 8: 95–100.
- 35 Wang F, Zhen TZ, Li W, Qu SY, He DY. Action of progesterone on contractile activity of isolated gastric strips in rats. World J Gastroenterol 2003; 9: 775–8.
- 36 Hazum E, Conn PM. Molecular mechanism of gonadotropin releasing hormone (GnRH) action, I. The GnRH receptor. Endocrinol Rev 1988; 9: 379–86.
- 37 Rabin D, McNeil LW. Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing infusion in normal females. J Clin Endocrinol Metab 1980; 51: 873–6.
- 38 Stojikovic SS, Tomic M. GnRH-induced calcium and current oscillations in gonadotrophs. Trends Endocrinol Metab 1996; 7: 379–84.
- 39 Heiner AM, Browne RM, Khanna R et al. Effect of centrally administered leuprolide acetate on myoelectric activity of the small intestine in rats (abstracts). Gastroenterology 1989; 96: 202.
- 40 Xu J, Zhu Z, Wu J et al. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model. Cancer Lett 2008; 259: 240–50.
- 41 Palsson OS, Drossman DA. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005; 34: 281–303.
- 42 Fetissov SO, Sinno MH, Coquerel Q et al. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008; 24: 854–89.
Citing Literature
